Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $24.3400 (1.71%) ($23.3800 - $25.1100) on Tue. Jan. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.79% (three month average) | RSI | 31 | Latest Price | $24.3400(1.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.3% a day on average for past five trading days. | Weekly Trend | IOVA declines -4.3% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(48%) ARKG(47%) IWO(44%) ARKK(42%) | Factors Impacting IOVA price | IOVA will decline at least -1.895% in a week (0% probabilities). VIXM(-28%) VXX(-16%) UUP(-10%) TLT(-2%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.895% (StdDev 3.79%) | Hourly BBV | 0 () | Intraday Trend | 2.8% | | | |
|
Resistance Level | $27.23 | 5 Day Moving Average | $26.07(-6.64%) | 10 Day Moving Average | $26.16(-6.96%) | 20 Day Moving Average | $27.23(-10.61%) | To recent high | -17.2% | To recent low | 35.6% | Market Cap | $3.564b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |